. . . . . . . . . . . . "[We examined whether the change of alpha(1)-adrenoceptor (alpha(1)-AR) subtype expression levels in the prostate occurred by administration of the alpha(1d)-AR-subtype-selective antagonist naftopidil to benign prostate hyperplasia (BPH) patients, and discussed the possible alternation of its effectiveness by the chronic administration of alpha(1)-AR antagonists.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2014-02-25"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:39:34+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .